Levothyroxine Sodium
- Product NDC
- 0904-6953
- 11-digit product format
- 009046953
- Labeler code
- 0904
- Product ID
- 0904-6953_942c00a3-b31c-48d5-a63d-6d394645ee1f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA209713
- Marketing category
- ANDA
- Marketing start
- 2019-03-20
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- .1 mg/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209713-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | |
| A209713-012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209713-001 | AB1 |
| A209713-001 | AB2 |
| A209713-001 | AB3 |
| A209713-002 | AB1 |
| A209713-002 | AB2 |
| A209713-002 | AB3 |
| A209713-003 | AB1 |
| A209713-003 | AB2 |
| A209713-003 | AB3 |
| A209713-004 | AB1 |
| A209713-004 | AB2 |
| A209713-004 | AB3 |
| A209713-005 | AB1 |
| A209713-005 | AB2 |
| A209713-005 | AB3 |
| A209713-006 | AB1 |
| A209713-006 | AB2 |
| A209713-006 | AB3 |
| A209713-007 | AB1 |
| A209713-007 | AB2 |
| A209713-007 | AB3 |
| A209713-008 | AB1 |
| A209713-008 | AB2 |
| A209713-008 | AB3 |
| A209713-009 | AB1 |
| A209713-009 | AB2 |
| A209713-009 | AB3 |
| A209713-010 | AB1 |
| A209713-010 | AB2 |
| A209713-010 | AB3 |
| A209713-011 | AB1 |
| A209713-011 | AB2 |
| A209713-011 | AB3 |
| A209713-012 | AB1 |
| A209713-012 | AB2 |
| A209713-012 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209713-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209713-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209713-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209713-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209713-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | 2019-01-18 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209713-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-001 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-001 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-002 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-002 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-003 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-003 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-004 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-004 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-004 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-005 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-005 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-006 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-006 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-007 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-007 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-008 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-008 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-009 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-009 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-009 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-010 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-010 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-010 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-011 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-011 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-011 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-012 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-012 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209713-012 | AB3 | 3 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-001 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-001 | AB3 | 3 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209713-002 | AB1 | 1 | 31067a03dcf5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVOTHYROXINE SODIUM | .1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9J765S329G | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 892246 | Internal RxNorm lookup |
| 966220 | Internal RxNorm lookup |
| 966221 | Internal RxNorm lookup |
| 966222 | Internal RxNorm lookup |
| 966224 | Internal RxNorm lookup |
| 966225 | Internal RxNorm lookup |
| 966248 | Internal RxNorm lookup |
| 966249 | Internal RxNorm lookup |
| 966253 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-6953-61 | Levothyroxine Sodium | 100 in 1 CARTON | TABLET | 100 | 8 | |
| 0904-6953-61 | Levothyroxine Sodium | 1 in 1 BLISTER PACK | TABLET | 1 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-6953-61 | EA - Each | 0904-6953 | 30862bcd-db80-45dc-9e20-81228e7170d3 | 1 | 2020-03-10 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 55f4c679-86cb-b97f-e063-6294a90ad5ef | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 55f67831-4680-edbf-e063-6294a90a1d36 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 544d67eb-8487-cb5d-e063-6394a90a3110 | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 53e84179-fe2a-5696-e063-6394a90a8566 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 53316e75-9897-4935-e063-6294a90a94cf | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | c8ae9dc4-836f-4912-80d7-684fd374f40a | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 52cce695-4363-8a2c-e063-6294a90a1bbf | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 52cd19e4-a4b3-ecee-e063-6394a90ac33b | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 51b68266-95d2-c166-e063-6294a90a534f | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 50fe00b3-6610-1cac-e063-6294a90af8ac | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 5100c561-0028-a3c0-e063-6394a90addeb | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | f94a81e2-49cd-430a-acda-1a47d5c5b59b | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 0235176b-ec39-44c4-a9e1-e0729a7989fa | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 7d07e932-7372-4c17-aa53-55087107fa52 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 2ecaa38f-8a6f-4536-8033-251d2c52ae64 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 991399a4-ff94-44d0-b1ba-1f89e7759498 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 87333260-fe57-4d99-886c-7c66cb063898 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 99df68ea-4de7-4825-a6d7-894c70d01c28 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 4f26f9dc-cf49-4b55-a6f7-f2f579893ee4 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ffc34bc6-5de5-addb-e053-6294a90a25be | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | 209713 ANDA209713 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | PSN | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | PSN | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | PSN | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966249 | levothyroxine sodium 175 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | PSN | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | PSN | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | PSN | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | PSN | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | PSN | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966220 | levothyroxine sodium 0.025 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966220 | levothyroxine sodium 0.025 MG Oral Tablet | SCD | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966221 | levothyroxine sodium 0.05 MG Oral Tablet | SCD | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966221 | levothyroxine sodium 0.05 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966222 | levothyroxine sodium 0.075 MG Oral Tablet | SCD | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966222 | levothyroxine sodium 0.075 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966253 | levothyroxine sodium 0.088 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966253 | levothyroxine sodium 0.088 MG Oral Tablet | SCD | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 892246 | levothyroxine sodium 0.1 MG Oral Tablet | SCD | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 892246 | levothyroxine sodium 0.1 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966248 | levothyroxine sodium 0.112 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966224 | levothyroxine sodium 0.125 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966224 | levothyroxine sodium 0.125 MG Oral Tablet | SCD | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966225 | levothyroxine sodium 0.15 MG Oral Tablet | SCD | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966225 | levothyroxine sodium 0.15 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966249 | levothyroxine sodium 0.175 MG Oral Tablet | SCD | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | SY | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | SY | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | SY | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966249 | levothyroxine sodium 175 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | SY | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | SY | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | SY | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | SY | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 8 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | SY | 333642fd-93ae-4dc0-9c83-6d6b163c1c74 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0904-6953-61 | 00904695361 | 100 BLISTER PACK in 1 CARTON (0904-6953-61) / 1 TABLET in 1 BLISTER PACK | 100 blister pack | 2019-03-20 | 0000-00-00 | No | No | Current |